Skip to content

Effect of multidimensional Ayurvedic management of Type II diabetes mellitus (Madhumeha): single group pre - post design clinical study

Effect of multidimensional Ayurvedic management of type II Diabetes mellitus (Madhumeha): single group pre - post design clinical study - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102103
Enrollment
30
Registered
2026-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

JS Ayurveda Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients between the age group of eighteen to seventy years of both genders will be selected. 2.Patients with fasting blood sugar from one hundred twenty six milligrams per deciliter or postprandial blood sugar from two hundred milligrams per deciliter, with HbA1C level more than six point five percent.

Exclusion criteria

Exclusion criteria: 1.Female patients who are pregnant or in the lactating period. 2.Patients aged less than eighteen years and more than seventy years. 3.Patients with HbA1C level more than eight point five percent. 4.Insulin dependent patients. 5.Patients with genetic syndromes associated with type two diabetes mellitus such as Down syndrome, Klinefelter syndrome, and Turner syndrome. 6.Patients having complications of diabetes such as nephropathy, neuropathy, retinopathy, carbuncles, and related conditions. 7.Patients with associated diseases that affect the outcome or completion of the treatment, such as cardiovascular disorders, autoimmune disorders, diabetic foot ulcer or gangrene, cancer, and kidney or liver disorders.

Design outcomes

Primary

MeasureTime frame
1.Fasting blood sugar value equal to or more than one hundred twenty six milligrams per deciliter. 2.Postprandial blood sugar value equal to or more than two hundred milligrams per deciliter. 3.Urine sugar ranging from positive to strongly positive. 4.Glycosylated hemoglobin or HbA1c level equal to or more than six point five percent. 5.Prabhuta Mutrata Normal urine output up to one thousand five hundred milliliters per day, with mild to severe increase ranging up to more than three thousand milliliters per day. 6.Avila Mutrata Urine sugar ranging from absent to severe presence. 7.Kshudhadhikya Appetite varying from usual intake to markedly increased intake with frequent meals and snacks. 8.Trishnadhikya Water intake ranging from normal to excessive, exceeding three liters per day. 9.Daurbalya Ability to perform activities ranging from normal routine work to inability to perform even mild exercise.Timepoint: Baseline and after 2 weeks

Secondary

MeasureTime frame
1.Fasting blood sugar value equal to or more than one hundred twenty six milligrams per deciliter. 2.Postprandial blood sugar value equal to or more than two hundred milligrams per deciliter. 3.Urine sugar ranging from positive to strongly positive. 4.Glycosylated hemoglobin or HbA1c level equal to or more than six point five percent. 5.Prabhuta Mutrata Normal urine output up to one thousand five hundred milliliters per day, with mild to severe increase ranging up to more than three thousand milliliters per day. 6.Avila Mutrata Urine sugar ranging from absent to severe presence. 7.Kshudhadhikya Appetite varying from usual intake to markedly increased intake with frequent meals and snacks. 8.Trishnadhikya Water intake ranging from normal to excessive, exceeding three liters per day. 9.Daurbalya Ability to perform activities ranging from normal routine work to inability to perform even mild exercise.Timepoint: Baseline and after 4 weeks

Countries

India

Contacts

Public ContactDr Krupali Patel

J S Ayurveda Mahavidyalaya and P D Patel Ayurveda Hospital

manishayu97@yahoo.com9979589865

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026